Zoetis

YTD

ALL

Trade Zoetis 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About ZTS

Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health technology. It operates through the United States and International geographical segments.

CEO

Kristin C. Peck

CEOKristin C. Peck

Employees

14,500

Employees14,500

Headquarters

Parsippany, New Jersey

HeadquartersParsippany, New Jersey

Founded

1952

Founded1952

Employees

14,500

Employees14,500

ZTS Key Statistics

Market cap

51.13B

Market cap51.13B

Price-Earnings ratio

19.94

Price-Earnings ratio19.94

Dividend yield

1.69%

Dividend yield1.69%

Average volume

2.71M

Average volume2.71M

High today

$121.53

High today$121.53

Low today

$118.60

Low today$118.60

Open price

$119.30

Open price$119.30

Volume

2.78M

Volume2.78M

52 Week high

$172.23

52 Week high$172.23

52 Week low

$113.29

52 Week low$113.29

Stock Snapshot

As of today, Zoetis(ZTS) shares are valued at $120.93. The company's market cap stands at 51.13B, with a P/E ratio of 19.94 and a dividend yield of 1.7%.

On 2026-04-15, Zoetis(ZTS) stock moved within a range of $118.60 to $121.53. With shares now at $120.93, the stock is trading +2.0% above its intraday low and -0.5% below the session's peak.

Trading volume for Zoetis(ZTS) stock has reached 2.78M, versus its average volume of 2.71M.

Over the past 52 weeks, Zoetis(ZTS) stock has traded between a high of $172.23 and a low of $113.29.

ZTS News

Simply Wall St 4d

How Zoetis’ Activist Clash Over Written-Consent Rights At Zoetis Has Changed Its Investment Story

In early April 2026, Zoetis Inc. filed a definitive proxy statement urging shareholders to vote against a written-consent rights proposal submitted by activist...

Nasdaq 4d

Zoetis Declines More Than Market: Some Information for Investors

In the latest close session, Zoetis (ZTS) was down 1.78% at $117.86. This change lagged the S&P 500's daily loss of 0.11%. At the same time, the Dow lost 0.56%,...

Simply Wall St 5d

Assessing Zoetis Valuation After Earnings Growth And Shareholder Rights Activism

Advertisement Why Zoetis stock is back in focus after fresh activism and recent earnings Zoetis (ZTS) is drawing attention after reporting organic revenue and...

Analyst ratings

61%

of 23 ratings

Buy

60.9%

Hold

39.1%

Sell

More ZTS News

Simply Wall St 6d

Is It Time To Revisit Zoetis After Recent Share Price Weakness?

Investors may be wondering if Zoetis at around US$116.80 is starting to look interesting again, or if the market is still pricing in too much optimism. The sha...

Nasdaq 6d

Zoetis Q3 2025 Earnings Call Transcript

AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX ADP SBUX MRNA AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX AD...

People also own

Based on the portfolios of people who own ZTS. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.